Prevalence of Myofascial Pain Syndrome and Efficacy of Trigger Point Injection in Patients with Incurable Cancer: A Multicenter, Prospective Observational Study (MyCar Study).
Hiroto IshikiHideaki HasuoYoshinobu MatsudaHiromichi MatsuokaShuji HiramotoMasaki HiguchiKohei YoshidaAkihiro TokoroYutaka HatanoTetsuo HoriJunya KinkawaMasanori NojimaPublished in: Pain medicine (Malden, Mass.) (2022)
MPS was common in patients with incurable cancer and the risk factor identified in this study was poor performance status. TPI could be a treatment option.